A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants.
Gustavo Valerio MalufRogério Jardim CaldasEduardo Rodrigues FregnaniPaulo Sérgio da Silva SantosPublished in: International journal of implant dentistry (2019)
The combination of adjuvant ozone therapy and surgical debridement was effective for the treatment of MRONJ; however, the risk of MRONJ may persist after the suspension of bevacizumab for 28 days.